Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 65 (2), 489-499

Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer

Affiliations

Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer

Cheng-Lin Zhu et al. Dig Dis Sci.

Abstract

Background: The Suvar, Enhancer of zeste, and Trithorax (SET), myeloid-Nervy-DEAF-1 (MYND) domain-containing protein 3 (SMYD3), was reported to be upregulated in various tumors. However, its role in pancreatic cancer progression remains unclear.

Aims: To explore the role of SMYD3 in the pancreatic cancer.

Methods: The expressions of SMYD3, caspase-3, and matrix metallopeptidase-2 (MMP-2) were detected in pancreatic cancer and non-tumor tissues by immunohistochemistry. The CCK-8 and transwell assays were performed to test proliferation, migration, and invasion ability in short hairpin RNA (shRNA-SMYD3) pancreatic cancer cell line SW1190. RT-PCR and Western blot were used to detect the expressions of SMYD3, caspase-3, and MMP-2 in SW1990 cell line and shRNA-SMYD3 SW1990 cell line.

Results: The expressions of SMYD3, caspase-3, and MMP-2 were upregulated in pancreatic cancer. The SMYD3 was positively associated with caspase-3 and MMP-2 expressions in pancreatic cancer tissues. SMYD3, TNM stages, histological differentiation, and lymph node metastasis were identified as an independent prognostic factor. Moreover, interfered SMYD3 expression in SW1990 cell line significantly reduced the cell proliferation, migration, and invasion. RT-PCR and Western blot showed the expression of MMP-2 decreased in shRNA-SMYD3 SW1990 cell line, but no significant change was observed in the caspase-3 expression.

Conclusions: The overexpression of SMYD3 promoted proliferation, migration, and invasion of pancreatic cancer, and SMYD3 may affect the pancreatic cancer progression by regulating MMP-2 rather than caspase-3.

Keywords: Caspase-3; MMP-2; Pancreatic neoplasms; SMYD3.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Cancer Cell. 2016 Mar 14;29(3):354-366 - PubMed

References

    1. Pol Przegl Chir. 2012 Aug;84(8):377-82 - PubMed

References

    1. Tohoku J Exp Med. 2017;243(3):219-226 - PubMed

References

    1. CA Cancer J Clin. 2018 Jan;68(1):7-30 - PubMed

References

    1. Nat Cell Biol. 2004 Aug;6(8):731-40 - PubMed

References

    1. Nat Struct Mol Biol. 2012 Jun 03;19(7):664-70 - PubMed

References

    1. CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32 - PubMed

References

    1. Cell. 1995 Jun 2;81(5):801-9 - PubMed

References

    1. J Am Coll Surg. 2015 Aug;221(2):579-90 - PubMed

References

    1. Cancer Res. 1997 Oct 15;57(20):4578-84 - PubMed

References

    1. Lancet. 2004 Mar 27;363(9414):1049-57 - PubMed

References

    1. Microbiol Immunol. 2016 Jun;60(6):407-17 - PubMed

References

    1. Expert Opin Ther Targets. 2017 Feb;21(2):145-157 - PubMed

References

    1. Nucleic Acids Res. 2015 Oct 15;43(18):8868-83 - PubMed

References

    1. Surg Oncol Clin N Am. 2001 Apr;10(2):383-92, x - PubMed

References

    1. Reproduction. 2015 Jul;150(1):21-30 - PubMed

References

    1. Int J Clin Exp Med. 2015 Jul 15;8(7):10225-34 - PubMed

References

    1. Cancer Biother Radiopharm. 2014 May;29(4):166-72 - PubMed

References

    1. Biochim Biophys Acta. 2016 Jul;1860(7):1466-74 - PubMed

References

    1. Nature. 1980 Mar 6;284(5751):67-8 - PubMed

References

    1. Pancreas. 2000 Nov;21(4):352-7 - PubMed

References

    1. Lancet. 2017 Mar 11;389(10073):1011-1024 - PubMed

References

    1. Med Oncol. 2011 Dec;28 Suppl 1:S91-8 - PubMed

References

    1. Oncotarget. 2016 Feb 9;7(6):7253-67 - PubMed

References

    1. Cancer Res. 2012 Feb 1;72(3):810-20 - PubMed

References

    1. Semin Cancer Biol. 2017 Feb;42:70-80 - PubMed

References

    1. Int J Surg. 2018 Apr;52:258-263 - PubMed

References

    1. Tumour Biol. 2015 Jun;36(6):4377-86 - PubMed

References

    1. Int J Oncol. 2015 Aug;47(2):592-600 - PubMed

References

    1. Oncotarget. 2015 Feb 28;6(6):4005-19 - PubMed

References

    1. J Am Coll Surg. 2015 Apr;220(4):530-6 - PubMed

References

    1. Am J Transl Res. 2017 Jan 15;9(1):1-14 - PubMed

References

    1. Oncotarget. 2017 Jul 4;8(27):45020-45029 - PubMed

References

    1. PLoS One. 2011;6(8):e23491 - PubMed

LinkOut - more resources

Feedback